| Immunology of Ebola Vaccine (NCT06100913) | Emory University | 2024-08-06 |
| KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis (NCT06400303) | Kyverna Therapeutics | 2024-08-06 |
| Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC) (NCT06549465) | Convergent Therapeutics | 2024-08-06 |
| Adagrasib + SRS for Patients With Metastatic KRAS G12C-mutated NSCLC With Untreated Brain Metastases (NCT06248606) | Ryan Gentzler, MD | 2024-08-06 |
| A Clinical Trial of TQB2102 for Injection in Non-small Cell Lung Cancer With HER2 Gene Abnormality (NCT06496490) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2024-08-06 |
| Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating Chronic Hepatitis B Virus (HBV) Infection (ENRICH) (NCT06491563) | Brii Biosciences Limited | 2024-08-06 |
| Evaluating Perioperative Outcomes: Dexmedetomidine vs Lignocaine in Laparoscopic Chlolecystectomy (NCT06740903) | Sahiwal medical college sahiwal | 2024-08-06 |
| A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized (NCT06509984) | Centre Hospitalier Universitaire de Nice | 2024-08-06 |
| Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma (NCT06435273) | AstraZeneca | 2024-08-05 |
| Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders Trial (NCT06488105) | Wake Forest University Health Sciences | 2024-08-05 |
| Comparison of Rescue Analgesia Requirement in Patients Undergoing Laparoscopic Cholecystectomy After Transversus Abdominal Plane (tap) Block Vs Local Anesthetic Wound Infiltration At the End of Surgery (NCT06803966) | Fazaia Ruth Pfau Medical College | 2024-08-05 |
| A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients. (NCT06349980) | Shanghai Henlius Biotech | 2024-08-05 |
| Prochlorperazine Maleate Versus Placebo for the Prophylaxis of Acute Mountain Sickness (NCT06450899) | University of Colorado, Denver | 2024-08-05 |
| Study of ADCs Combined With Adebrelimab in HER2-negative Advanced Breast Cancer (NCT06433609) | Beijing GoBroad Hospital | 2024-08-05 |
| Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension (NCT06394973) | Laboratoires Thea | 2024-08-05 |
| A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity (NCT06565611) | Palatin Technologies, Inc | 2024-08-05 |
| Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy (NCT06449209) | BioNTech SE | 2024-08-05 |
| Auger Molecular Therapy (AMT) for Malignant Cutaneous Lesions Treatment (NCT04807257) | NanoRay Biotech Co., Ltd. | 2024-08-05 |
| Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (NCT06308588) | M.D. Anderson Cancer Center | 2024-08-05 |
| Iptacopan in Patients With ANCA Associated Vasculitis (NCT06388941) | Novartis Pharmaceuticals | 2024-08-05 |
| Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder (NCT06480383) | Intra-Cellular Therapies, Inc. | 2024-08-05 |
| A Study of Microwave Ablation Combined With Immunotherapy ± Anti-angiogenic Drugs in the Treatment of Solid Tumors (NCT06537505) | Beidahuang Industry Group General Hospital | 2024-08-05 |
| Palmitoylethanolamide for Chronic Inflammatory Pain Conditions (NCT06273462) | Navy Medical Center San Diego | 2024-08-05 |
| Study of UC-MSC in DMD Patients (NCT06579352) | MED Institute Inc. | 2024-08-05 |
| Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-B ) (NCT06492265) | Yongjun Wang | 2024-08-04 |
| Adaptive Therapy for Post-Second-Line Advanced Breast Cancer (NCT06533722) | Sun Yat-sen University | 2024-08-04 |
| Trial of JYB1904 in Chronic Spontaneous Urticaria. (NCT06509334) | Jemincare | 2024-08-04 |
| TB006 for Autism Spectrum Disorder (NCT06500637) | Rossignol Medical Center | 2024-08-03 |
| A Phase Ib/II Study of Adebrelimab in Combination with Capecitabine and Oxaliplatin in Cancer (NCT06776770) | Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center | 2024-08-03 |
| A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Unresectable Locally Advanced or Recurrent Metastatic Triple-negative Breast Cancer (NCT06471205) | Sichuan Baili Pharmaceutical Co., Ltd. | 2024-08-02 |
| Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer (NCT05898828) | National Cancer Institute (NCI) | 2024-08-02 |
| Effect of Rifaximin on Gut Bacterial Flora Post Stem Cell Transplant in Patients With Acute Leukemia (NCT06058572) | Tata Memorial Centre | 2024-08-02 |
| Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia (NCT06544798) | MeiraGTx, LLC | 2024-08-02 |
| Lattice Radiotherapy for Dose-Escalated Palliation of Bulky Tumors (NCT06416007) | University of Cincinnati | 2024-08-02 |
| Prospective Pilot Trial to Address Feasibility and Safety of Oral Zinc in GNAO1 Associated Disorders (NCT06412653) | Children's University Hospital Cologne, Germany | 2024-08-02 |
| Comparison of Adjuvant Treatment With 177Lu-DOTATATE to Best Supportive Care in Patients After Resection of Neuroendocrine Liver Metastases (NCT05987176) | Imperial College London | 2024-08-02 |
| Racecadotril Versus Standard Treatment in Decreasing the Duration of Acute Diarrhoea in Children (NCT06529497) | Liaquat National Hospital & Medical College | 2024-08-02 |
| Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia (NCT06523556) | Uma Borate | 2024-08-02 |
| The Efficacy and Safety of Tislelizumab Combined With Anlotinib and S1 Plus Oxaliplatin as Neoadjuvant Therapy for the Locally Advanced Adenocarcinoma of Esophagogastric Junction (NCT06396585) | Fujian Cancer Hospital | 2024-08-01 |
| AK112 Plus AP Regimen for Operable Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT06537011) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-08-01 |
| Onvansertib in Combination With Gemcitabine and Nab-paclitaxel for the Treatment of Patients With Locally-advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma (NCT06398587) | OHSU Knight Cancer Institute | 2024-08-01 |
| A Phase 2 Trial of JKN24011 in COPD (NCT07440524) | Joincare Pharmaceutical Group Industry Co., Ltd | 2024-08-01 |
| A Prospective Cohort Study of Proton and Photon Therapy for Left-sided Breast Cancer. (NCT06677879) | Shanghai Proton and Heavy Ion Center | 2024-08-01 |
| Open Label Study to Evaluate the Safety and Efficacy of NDV01 KIT in High Grade NMIBC (NCT06663137) | Relmada Therapeutics, Inc. | 2024-08-01 |
| Effect of Low Molecular Heparin on Pregnancy Outcome With Protein S Deficiency (NCT06531525) | Peking University People's Hospital | 2024-08-01 |
| Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma (NCT06530823) | Eastern Hepatobiliary Surgery Hospital | 2024-08-01 |
| Effect of Nutritional Intervention Based on Prediction Model on Adult Umbilical Cord Blood Transplantation Patients (NCT06553274) | Anhui Provincial Hospital | 2024-08-01 |
| Intra-lesional ACE Inhibitor for Treatment of Hypertrophic Scars (NCT05259137) | Nova Scotia Health Authority | 2024-08-01 |
| SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST (NCT06208748) | Sarcoma Alliance for Research through Collaboration | 2024-08-01 |
| Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission. (NCT06608732) | Institute of Hematology & Blood Diseases Hospital, China | 2024-08-01 |
| Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF) (NCT06327100) | M.D. Anderson Cancer Center | 2024-08-01 |
| Efficacy and Resistant Mechanism of Eribulin and Bevacizumab for Advanced HER2 Negative Breast Cancer (NCT06539559) | Wang Jiayu | 2024-08-01 |
| Stem Cell Derived Exome for Treatment of Diabetic Foot (NCT06480123) | Second Affiliated Hospital of Guangzhou Medical University | 2024-08-01 |
| Study of the Drug B11-FC (Botulism Treatment) (NCT06580236) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2024-08-01 |
| Study of SPG302 in Adults With Schizophrenia (NCT06442462) | Spinogenix | 2024-08-01 |
| Vonafexor ALPort Syndrome Efficacy & Safety TRIAl-1 (ALPESTRIA-1) (NCT06425055) | Enyo Pharma | 2024-08-01 |
| Anti-bacterial Potential of Nano Calcium Hydroxide as an Intracanal Medication (NCT06196515) | British University In Egypt | 2024-08-01 |
| Efficacy and Safety of Eliglustat in Chinese Pediatric Patients With Gaucher Disease Type 1 and Type 3 (NCT06523517) | Peking Union Medical College Hospital | 2024-08-01 |
| The MUSE Study for Menopausal Arthralgia (NCT06530459) | National University Hospital, Singapore | 2024-08-01 |
| Coenzyme Q10 and Chemotherapeutic Toxicity in Breast Cancer Patients (NCT06570811) | Damanhour University | 2024-08-01 |
| Anti-CD38 Antibody Treating Children With Primary Immune Thrombocytopenia (ITP) (NCT06838962) | Institute of Hematology & Blood Diseases Hospital, China | 2024-08-01 |
| Efficacy of Topical 85% TCA in the Treatment of LSIL After Low-grade Abnormality of Screening Test: a Randomized Controlled Trial (NCT06525870) | Department of Medical Services Ministry of Public Health of Thailand | 2024-08-01 |
| Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CRIS-2 Trial） (NCT06509568) | Zhejiang Cancer Hospital | 2024-08-01 |
| Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine (NCT06782646) | The University of Hong Kong | 2024-08-01 |
| Polatuzumab, Rituximab and Orelabrutinib Combination Regimen (PRO) in the Treatment of Elderly Frail Patients with Treatment-naive Non-GCB DLBCL (NCT06530511) | Affiliated Hospital of Nantong University | 2024-08-01 |
| Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD) (NCT06423781) | Biohaven Therapeutics Ltd. | 2024-08-01 |
| Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer (NCT06435260) | Hebei Medical University Fourth Hospital | 2024-08-01 |
| Transcranial Magnetic Stimulation + Language Therapy to Treat Subacute Aphasia (NCT06968663) | University of Pennsylvania | 2024-08-01 |
| EleVation carE: a Randomized Controlled Trial on the Prevention of Acute Mountain Sickness With Suxiao Jiuxin Pill (NCT06531161) | Peking University First Hospital | 2024-08-01 |
| Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD) (NCT06362707) | Helse Stavanger HF | 2024-08-01 |
| A Phase II Study of Anti-EGFR Antibody-drug Conjugate (ADC) Combine With CDK4/6 Inhibitors Posterior Line in the Treatment of Recurrent/Metastatic CDKN2A Gene Variant Head and Neck Squamous Cell Carcinoma (NCT06509997) | Lei Liu | 2024-08-01 |
| A Study of HRS9531 Injection in Obese Subjects With Obstructive Sleep Apnea (NCT06565871) | Fujian Shengdi Pharmaceutical Co., Ltd. | 2024-08-01 |
| Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial) (NCT06517511) | Sun Yat-sen University | 2024-08-01 |
| Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia (NCT07513038) | Boston Children's Hospital | 2024-08-01 |
| Clinical Efficiency of Bioactive Pit and Fissure Sealant (NCT06493942) | Cairo University | 2024-08-01 |
| A Study on the Combination of Sintilimab, Ramucirumab and Chemotherapy for First-line Treatment of Gastric Cancer With Liver Metastasis (NCT06564298) | The First Affiliated Hospital with Nanjing Medical University | 2024-08-01 |
| Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT) (NCT06216249) | Jonsson Comprehensive Cancer Center | 2024-08-01 |
| A Multicenter Randomized Controlled Study of Interventional Treatment for Operable Stage Ⅱ-Ⅲ Non-small Cell Lung Cancer With Potential Recurrence as Minimal Residual Disease(MRD) Positive (NCT06524518) | Xuanwu Hospital, Beijing | 2024-08-01 |
| The Impact of Medication Timing Adjustment on the Effect of Novel Hormonal Therapy (NCT06505278) | Sun Yat-sen University | 2024-08-01 |
| Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury (NCT05826912) | University of California, San Francisco | 2024-08-01 |
| Study of Clinical Features and Efficacy of Small Intestinal Bacterial Overgrowth in Patients With Abdominal Distension (NCT06518850) | Peking Union Medical College Hospital | 2024-08-01 |
| A Phase 2, Single Arm Study of Cabozantinib in Patients With Hepatocellular Carcinoma Who Have Received Prior Atezolizumab and Bevacizumab (NCT06535737) | Chulalongkorn University | 2024-08-01 |
| ANIMATOR - RehUP BCI Controlled Robotic Therapy vs. an Attention-based Control (NCT06538506) | University of Calgary | 2024-08-01 |
| Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers (NCT06492070) | Emory University | 2024-08-01 |
| Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC (NCT05805631) | Taipei Veterans General Hospital, Taiwan | 2024-08-01 |
| Pilot Study of Preoperative Intestinal Training Using Antegrade Ileostomy Infusion (NCT06461559) | University of California, San Diego | 2024-08-01 |
| Safety, Tolerability, and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants With SOD1 Amyotrophic Lateral Sclerosis (SOD1-ALS) (NCT06100276) | UniQure Biopharma B.V. | 2024-08-01 |
| Effect of Probiotics on Infantile Colic Symptoms (NCT06385054) | Lallemand Health Solutions | 2024-08-01 |
| Effect of Fluid Resuscitation on Lactate in Traumatic Injury Patients (NCT06370975) | Assiut University | 2024-08-01 |
| To Evaluate the Efficacy of Adebrelimab Combined With Chemotherapy After HIFU Induction Neoadjuvant Therapy HR+/HER2- Breast Cancer (NCT06470633) | The First Affiliated Hospital with Nanjing Medical University | 2024-08-01 |
| A Comparative Study of Glucocorticoids Efficacy in Acute Respiratory Distress Syndrome (NCT06496997) | Fayoum University | 2024-08-01 |
| A Phase II Study of MRG003 Injection Combined With Pucotenlimab Injection ± Cisplatin Injection in the Neoadjuvant Treatment Locally Advanced EGFR-positive Head and Neck Squamous Cell Carcinoma (NCT06530914) | Lei Liu | 2024-08-01 |
| Neoadjuvant Therapy With Weekly Utidelone Combined With Cisplatin for Patients With Breast Cancer (NeoURANIA) (NCT06510465) | RenJi Hospital | 2024-08-01 |
| Propionic Acid for Multiple Sclerosis: Safety and Benefits (NCT07595081) | Salzburger Landeskliniken | 2024-08-01 |
| A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder (NCT06126653) | Aardvark Therapeutics, Inc. | 2024-08-01 |
| Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy (NCT06523049) | Hao Zeng | 2024-08-01 |
| Trial to Evaluate the Safety and Efficacy of EB-203 in Patients With Neovascular Age-related Macular Degeneration (NCT06487039) | EyebioKorea, Inc. | 2024-08-01 |
| Estimates of the Short-term Efficacy of Talineuren (TLN) and Placebo in Patients With Parkinson Disease (NCT06431971) | InnoMedica Schweiz AG | 2024-08-01 |
| Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial (NCT06288113) | Jonsson Comprehensive Cancer Center | 2024-08-01 |
| Radiotherapy or Surgery Combined With Intense Androgen Deprivation Therapy for mCRPC (NCT06992232) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2024-08-01 |